Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intrabodies as therapeutic agents.

Roland E Kontermann1

  • 1Vectron therapeutics AG, Rudolf-Breitscheid-Str. 24, 35037 Marburg, Germany. kontermann@vectron-ag.com

Methods (San Diego, Calif.)
|August 18, 2004
PubMed
Summary

Intracellular antibodies (intrabodies) show promise as therapeutic agents. These antibodies target various diseases, including cancer and infections, by interacting with intracellular proteins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comparison of Cost-Effective Sensors for a Fluorescence-Based Detection System Used in Biodiagnostic Devices.

Biosensors·2026
Same author

Novel bispecific T-cell engagers overcoming acquired EGFR resistance.

mAbs·2026
Same author

BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer.

Cell death & disease·2026
Same author

Oncolytic adenoviruses encoding bispecific T cell engagers or a novel trispecific T cell engager for dual-targeting of c-MET and EGFR.

Molecular therapy. Oncology·2026
Same author

The making of multispecific immunoglobulins - a clinical perspective.

mAbs·2026
Same author

Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3.

Frontiers in immunology·2025

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Medicine

Background:

  • Intracellular antibodies (intrabodies) have emerged as a significant area of research in the last decade.
  • Their development is driven by the potential for targeted intracellular therapies.

Purpose of the Study:

  • To summarize the advancements in the development of intrabodies.
  • To review the diverse therapeutic applications of intrabodies.

Main Methods:

  • Review of scientific literature on intrabody development and applications.
  • Analysis of intrabody mechanisms against various disease targets.

Main Results:

  • Intrabodies can be engineered against a wide array of intracellular targets.
  • Successful preclinical and clinical investigations demonstrate therapeutic potential.

Conclusions:

  • Intrabodies represent a versatile platform for treating diseases at the cellular level.
  • Their applications extend to oncology, infectious diseases, and protein-related disorders.

Related Experiment Videos